FISH
Proceeds from a recent European public offering will fund commercialization of the French company's Ikoniscope20 platform in the US and EU.
With New Partnerships, Diaceutics Works to Standardize CDx Testing Globally
The deals with three quality assessment organizations will contribute to the firm's goal of connecting pharmaceutical companies, diagnostic firms, and laboratories.
Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer
The approval was based on data showing superior efficacy for Alunbrig compared to Pfizer's Xalkori, especially in patients with brain metastasis.
The company's approach involves using both fluorescence in situ hybridization and next-generation sequencing to provide clinicians with information.
The team will present the results to the US Food and Drug Administration as part of a 510(k) application in order to commercialize the technology with Biofluidica.